Senior Management

Dana Cost
Chief Executive Officer

Ms. Cost possesses over 20 years of Human Resources and organizational development experience in a multitude of industries. She graduated from Philadelphia University with a Bachelor’s in Accounting and then spent 10 years in the retail management field overseeing 50+ employees with their EDI/purchasing system.

Ms. Cost joined QDS in 2011 initially as HR Manager and has continued to expand her responsibilities. She oversees benefits, compensation, employee relations, diversity, staffing management for projects, adherence to timelines, and proposals to new clients and business development.

In 2018, Ms. Cost’s expanded her role within QDS to assist with corporate strategy, and oversee operations ensuring that staff continue to provide superior customer service while always delivering the highest quality output. She is a member of the corporate Board of Directors.

Victoria M. Marino
Chief Operating Officer

Ms. Marino has 25 years experience in various positions within Clinical Research and Operations with biopharmaceutical companies.  She has been a presenter at various meetings and seminars on Drug Development, GCPs, and Clinical management.

Ms. Marino graduated from Hartwick College with a BS in Medical Technology. After spending many years as a bench scientist in Hematology/Oncology, she joined the pharmaceutical industry in 1991 as a Phase 1 site manager.   In 1995 she joined Centocor and held positions within Data Management, Quality Assurance, and Clinical Research.  In 1997, she joined Astra-Merck, as a Clinical Program Manager with oversight and management of Nexium® NDA and sNDA work.  She had held positions of increasing responsibility at the Covalent Group, Dermik Laboratories and Shire Pharmaceuticals in Clinical development and commercialization prior to joining QDS in 2005.

Since joining QDS as Project Director, she now oversees Clinical operations, data management and biostatistics, and is on the board of directors.

Ms. Marino has contributed to numerous successful NDA, PLA and sNDA submissions in her career.

Lisha Morancie
Chief Financial Officer

Ms. Morancie has over 10-years of experience in corporate Finance and Accounting. She has worked in various industries throughout the years including clinical research, trust funds, health care, and non-profit housing. Ms. Morancie has managed the day-to-day financials of both large and small companies across the United States of America.

Ms. Morancie graduated from Temple University’s Fox School of Business in 2008 with a Bachelor’s in Finance and Risk Management. She obtained her Master’s in Business Administration in 2011 with a concentration in Business Administration and Health Care Management.

Since joining QDS in 2013, Ms. Morancie has managed the company’s profitability, financial forecasting, year-end financial preparation, assisted with budget proposals, and oversees the performance of all ongoing studies. Ms. Morancie is a member of the corporate Board of Directors.

John Paige
Chief Information Officer

Mr. Paige has focused on implementation and management of IT solutions, specializing in Microsoft based technologies, networks, and security for over 20 years.

A graduate of The Pennsylvania State University, Mr. Paige joined Intelligent Electronics in 1992 eventually becoming IT, Systems Engineer for their subsidiary XLConnect Solutions, Inc., providing network, server, and workstation support.  XLConnect was acquired by Xerox in 1998, and he continued working for Xerox Global Services as Senior Systems Manager, managing a data center and IT support services for over 1000 employees before joining QDS in 2007.

In his role with QDS, Mr. Paige manages Information Technology, supporting QDS’ network and systems, and Clinical Information Services supporting the QDR application, and is on the board of directors.

Ellina Babouchkina, BS, RN, MD
Director, Data Operations and Clinical Programming (CDISC SME)

Ms. Babouchkina has over 20 years in the CRO/Pharmaceutical industry and SAS programming environment with sound knowledge of clinical study data collection, extraction, manipulation, analysis and reporting in a multitude of therapeutic areas.

She has over 10 years of extensive knowledge and experience with CDISC Standards, mapping data and creating/validating SAS datasets and xpt files based on CDISC SDTM versions 3.1, 3.1.1, 3.1.2, 3.1.3, 3.2 and 3.3 Implementation Guides. She assisted in presentation of Seminar “Realizing Efficiencies in the CDISC Process” during the 44th DIA Annual Meeting.

As a CDISC Platinum Member and part of the CDISC Advisory Council, Ellina has participated in the processes of nominating candidates for the CDISC Board of Directors, CAC Face-to-Face Meetings and teleconferences with CDISC Board of Directors and Regulators from FDA and PMDA for discussions on CAC and CDISC activities. As a CDISC SDS (Submission Data Standards) team member, she participates in the internal review of the new documents, TAUGs and SDTM; attends CDISC Intra- and Inter- Change Face to Face meetings and SDS Extended Leadership Team Meetings. Ellina was involved in SDTMIG v3.3 preparation for release/publication as a member of CDISC Publication Team. For over the last 2 years Ellina has been a CDISC Submission Data Standards Team representative on CDISC Global Governance Group.

During her 20 year tenure at QDS, she has worked as a Clinical Programmer Analyst/Database Analyst; Manager, Clinical Information Systems; Senior Manager, Quality Assurance – Data Integration, CDISC Integration and Validation Expert. Since 2012, as a Senior Manager, Data Integration and Standardization, she oversaw and supported all of the company’s SDTM creation and validation processes. Since 2017, she oversees all Statistical Programming personnel and activities, including scheduling of programming tasks, resource planning, timelines and quality of all QDS deliverables to our clients.

Ellina possesses a Bachelor of Science, Registered Nurse; Medical Doctorate and Certificate Program in Computer Science degrees.